No impact of immunomodulatory treatments on SARS-CoV-2 (COVID-19) vaccine outcomes: A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic Cosmos database

J Am Acad Dermatol. 2024 Mar 13:S0190-9622(24)00485-7. doi: 10.1016/j.jaad.2024.03.004. Online ahead of print.

¹ Medical Scientist Training Program, Ohio State University Wexner Medical Center, Columbus, Ohio.
² Dermatology, Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: Benjamin.Kaffenberger@osumc.edu.

No abstract available

Keywords: COVID-19; hidradenitis suppurativa; immunotherapy; psoriasis; vaccine efficacy.